147 related articles for article (PubMed ID: 1952873)
21. Resistance of Aeromonas hydrophila to beta-lactam antibiotics.
Zemelman R; Gonzalez C; Mondaca MA; Silva J; Merino C; Dominguez M
J Antimicrob Chemother; 1984 Dec; 14(6):575-9. PubMed ID: 6335147
[TBL] [Abstract][Full Text] [Related]
22. Distribution and characterization of beta-lactamases of mycobacteria and related organisms.
Kwon HH; Tomioka H; Saito H
Tuber Lung Dis; 1995 Apr; 76(2):141-8. PubMed ID: 7780097
[TBL] [Abstract][Full Text] [Related]
23. Antibiotic susceptibility of anaerobic bacteria with special reference to Bacteroides fragilis.
Dornbusch K; Nord CE; Olsson-Liljeqvist B
Scand J Infect Dis Suppl; 1979; (19):17-25. PubMed ID: 37593
[TBL] [Abstract][Full Text] [Related]
24. The role of beta-lactamase in staphylococcal resistance to penicillinase-resistant penicillins and cephalosporins.
McDougal LK; Thornsberry C
J Clin Microbiol; 1986 May; 23(5):832-9. PubMed ID: 3011847
[TBL] [Abstract][Full Text] [Related]
25. A possible role of R plasmids in bacterial permeability for beta-lactam antibiotics.
Ikeuchi T; Osada Y
Microbiol Immunol; 1981; 25(4):333-44. PubMed ID: 7019627
[TBL] [Abstract][Full Text] [Related]
26. The effect of beta-lactamase stability, penetration, and target affinity on the activity of cefazolin, cefamandole, cefoxitin, and cefuroxime.
Harper PB
Clin Ther; 1984; 6(3):310-24. PubMed ID: 6609771
[TBL] [Abstract][Full Text] [Related]
27. beta-Lactamase activity in human pus.
Bryant RE; Rashad AL; Mazza JA; Hammond D
J Infect Dis; 1980 Oct; 142(4):594-601. PubMed ID: 6969281
[TBL] [Abstract][Full Text] [Related]
28. In vitro protection of group A beta-hemolytic streptococci from penicillin and cephalothin by Bacteroides fragilis.
Brook I; Yokum P
Chemotherapy; 1983; 29(1):18-23. PubMed ID: 6339177
[TBL] [Abstract][Full Text] [Related]
29. Staphylococcal beta-lactamase and efficacy of beta-lactam antibiotics: in vitro and in vivo evaluation.
Chapman SW; Steigbigel RT
J Infect Dis; 1983 Jun; 147(6):1078-89. PubMed ID: 6602190
[TBL] [Abstract][Full Text] [Related]
30. Beta-lactamase activity in mycobacteria other than M. tuberculosis.
Coira A; Salvadó M; Reig R; Chaves J; Segura C
J Chemother; 1995 Apr; 7(2):106-8. PubMed ID: 7666114
[TBL] [Abstract][Full Text] [Related]
31. Effect of interaction between outer membrane permeability and beta-lactamase production on resistance to beta-lactam agents in gram-negative bacteria.
Sawai T; Yamaguchi A; Hiruma R
Rev Infect Dis; 1988; 10(4):761-4. PubMed ID: 3055174
[TBL] [Abstract][Full Text] [Related]
32. Sensitivity of Escherichia coli to various beta-lactams is determined by the interplay of outer membrane permeability and degradation by periplasmic beta-lactamases: a quantitative predictive treatment.
Nikaido H; Normark S
Mol Microbiol; 1987 Jul; 1(1):29-36. PubMed ID: 3330755
[TBL] [Abstract][Full Text] [Related]
33. Inactivation of cefazolin, cephaloridine, and cephalothin by methicillin-sensitive and methicillin-resistant strains of Staphylococcus aureus.
Regamey C; Libke RD; Engelking ER; Clarke JT; Kirby MM
J Infect Dis; 1975 Mar; 131(3):291-4. PubMed ID: 1039311
[TBL] [Abstract][Full Text] [Related]
34. [A study of beta-lactamase activity of mycobacteria and clinical trial of penicillin/beta-lactamase inhibitor combinations in the treatment of drug-resistant Mycobacterium tuberculosis].
Nakagawa Y; Shimazu K; Ebihara M; Aman K
Kekkaku; 1999 May; 74(5):447-52. PubMed ID: 10386034
[TBL] [Abstract][Full Text] [Related]
35. Inactivation of cephalothin and cephaloridine by Staphylococcus aureus.
Benner EJ; Bennett JV; Brodie JL; Kirby WM
J Bacteriol; 1965 Dec; 90(6):1599-604. PubMed ID: 5175748
[TBL] [Abstract][Full Text] [Related]
36. Activity of beta-lactamase inhibitor combinations on Escherichia coli isolates exhibiting various patterns of resistance to beta-lactam agents.
Vanjak D; Muller-Serieys C; Picard B; Bergogne-Berezin E; Lambert-Zechovsky N
Eur J Clin Microbiol Infect Dis; 1995 Nov; 14(11):972-8. PubMed ID: 8654448
[TBL] [Abstract][Full Text] [Related]
37. Reliability of cefaclor, cefazolin, cefamandole, and cephalothin disks to predict susceptibility of Enterobacteriaceae, Staphylococcus species, and Haemophilus influenzae.
Barry AL; Jones RN; Thornsberry C
Am J Clin Pathol; 1985 Nov; 84(5):643-8. PubMed ID: 3877452
[TBL] [Abstract][Full Text] [Related]
38. Characterization of mechanisms of resistance to beta-lactam antibiotics in methicillin-resistant strains of Staphylococcus saprophyticus.
Stratton CW; Gelfand MS; Gerberding JL; Chambers HF
Antimicrob Agents Chemother; 1990 Sep; 34(9):1780-2. PubMed ID: 2285290
[TBL] [Abstract][Full Text] [Related]
39. Factors contributing to resistance to beta-lactam antibiotics in Bacteroides fragilis.
Olsson B; Dornbusch K; Nord CE
Antimicrob Agents Chemother; 1979 Feb; 15(2):263-8. PubMed ID: 426517
[TBL] [Abstract][Full Text] [Related]
40. Structures of the acyl-enzyme complexes of the Staphylococcus aureus beta-lactamase mutant Glu166Asp:Asn170Gln with benzylpenicillin and cephaloridine.
Chen CC; Herzberg O
Biochemistry; 2001 Feb; 40(8):2351-8. PubMed ID: 11327855
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
